BioLight Life Sciences Ltd.

TASE:BOLT Stock Report

Market Cap: ₪21.8m

BioLight Life Sciences Management

Management criteria checks 4/4

BioLight Life Sciences' CEO is Yaacov Michlin, appointed in May 2020, has a tenure of 4.5 years. total yearly compensation is ₪1.31M, comprised of 78.8% salary and 21.2% bonuses, including company stock and options. directly owns 1.07% of the company’s shares, worth ₪233.50K. The average tenure of the management team and the board of directors is 4.9 years and 6.6 years respectively.

Key information

Yaacov Michlin

Chief executive officer

₪1.3m

Total compensation

CEO salary percentage78.8%
CEO tenure4.5yrs
CEO ownership1.1%
Management average tenure4.9yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Yaacov Michlin's remuneration changed compared to BioLight Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-₪6m

Mar 31 2024n/an/a

-₪24m

Dec 31 2023₪1m₪1m

-₪26m

Sep 30 2023n/an/a

-₪28m

Jun 30 2023n/an/a

-₪29m

Mar 31 2023n/an/a

-₪10m

Dec 31 2022₪2m₪1m

-₪8m

Sep 30 2022n/an/a

-₪7m

Jun 30 2022n/an/a

-₪5m

Mar 31 2022n/an/a

-₪3m

Dec 31 2021₪1m₪969k

₪382k

Compensation vs Market: Yaacov's total compensation ($USD347.27K) is about average for companies of similar size in the IL market ($USD425.15K).

Compensation vs Earnings: Yaacov's compensation has been consistent with company performance over the past year.


CEO

Yaacov Michlin (55 yo)

4.5yrs

Tenure

₪1,305,000

Compensation

Mr. Yaacov Michlin serves as Director at AEYE Health Inc. He serves as Chairman at Peripherex. He was the Chief Executive Officer of Brainsway Ltd. from April 2017 until September 2019.Mr. Michlin was the...


Leadership Team

NamePositionTenureCompensationOwnership
Yaacov Michlin
Chief Executive Officer4.5yrs₪1.31m1.07%
₪ 233.5k
Yifftach Biel
Chief Financial Officer9.5yrs₪744.00kno data
Karin Gurevitz
VP, Legal Advisorno data₪659.00kno data
Ron Neumann
Chief Medical Officer & Member of Scientific Advisory Board4.9yrsno datano data

4.9yrs

Average Tenure

54yo

Average Age

Experienced Management: BOLT's management team is considered experienced (4.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ron Neumann
Chief Medical Officer & Member of Scientific Advisory Boardno datano datano data
Israel Makov
Chairman of the Board13.6yrs₪432.00k14.03%
₪ 3.1m
Sharon Malka
Independent External Directorless than a yearno datano data
Rina Shafir
Independent External Director6.6yrsno datano data
Suzana Nahum-Zilberberg
Vice Chairman of the Board4.3yrs₪225.00kno data
Alla Felder
Independent External Director4.7yrsno datano data
Ron Mayron
Independent Director9.3yrs₪149.00kno data
Jacob Faigenbaum
Independent Director7.5yrsno datano data
Vincente Anido
Member of Scientific Advisory Boardno datano datano data
Jeffrey Goldberg
Member of Scientific Advisory Boardno datano datano data
Anat Loewenstein
Member of Scientific Advisory Boardno datano datano data
Joseph Tauber
Member of Scientific Advisory Boardno datano datano data

6.6yrs

Average Tenure

61yo

Average Age

Experienced Board: BOLT's board of directors are considered experienced (6.6 years average tenure).